14158 Results (Page 551 of 567)
All Market Research Reports
Spain Constipation Therapeutics Market Analysis
Spain Constipation Therapeutics Market was valued at $351 Mn in 2022 and is estimated to reach $539 Mn in 2030, exhibiting a CAGR of 5.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati, and Sanofi.
Mexico Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Mexico Clinical Nutrition for Chronic Kidney Diseases Market was valued at $23.60 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $36.1 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and advancements in medical research. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Japan Herbal Supplements Market Report
The Japan Herbal Supplements Market was valued at $326.95 Mn in 2023 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $514.80 Mn by 2030. The key drivers of this industry include an aging population, preventive healthcare, and cultural orientation. The industry is primarily dominated by players such as Tsumura & Co, Eisai Co., Ltd, Herbalife, and NOW Foods among others.
France Brugada Syndrome Market Analysis
The France Brugada Syndrome Market was valued at $33 Mn in 2023 and is predicted to grow at a CAGR of 6.8% from 2023 to 2030, to $52.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increased awareness and diagnosis, and technological innovations in treatment. The prominent players of the France Brugada Syndrome Market are Abbott Laboratories, Medtronic, Siemens Healthcare, Sanofi, and Abivax, among others.
Vietnam Actinic Keratosis Therapeutic Market Analysis
The Vietnam Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 5.13% during the forecast period, rising from $34 Mn in the year 2022 and reaching $51 Mn by the year 2030. The Vietnam Actinic Keratosis Market is driven by factors like the introduction of new products, a focus on market penetration in developing regions, and the rising demand and acceptance of minimally invasive procedures. Key players in the Vietnam Actinic Keratosis Therapeutic Market include global market players like LEO Pharma, Galderma, Sun Pharmaceuticals, Bayer, Alma Lasers, Syneron Candela, and some domestic players like Vinpharmex and Traphaco
France Clinical Nutrition for Chronic Kidney Diseases Market Analysis
France Clinical Nutrition for Chronic Kidney Diseases Market was valued at $43.20 Mn in 2023 and is predicted to grow at a CAGR of 5.03% from 2023 to 2030, to $60.90 Mn by 2030. The key drivers of this industry include rising CKD prevalence, aging populations, and technology advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Malaysia Herbal Supplements Market Report
Short Description The Malaysia Herbal Supplements Market was valued at $8.46 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $13.06 Mn by 2030. The key drivers of this industry include disease burden, health consciousness, and government initiatives. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife Nutrition, Dabur, and Patanjali Ayurved among others.
Germany Brugada Syndrome Market Analysis
The Germany Brugada Syndrome Market was valued at $43.9 Mn in 2023 and is predicted to grow at a CAGR of 6.0% from 2023 to 2030, to $66 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Germany Brugada Syndrome Market are Bayer, Roche, Siemens Healthineers, Sanofi, Thermo Fisher Scientific, and Novartis, among others.
Brazil Adult Malignant Glioma Therapeutics Market Analysis
The Brazil Adult Glioma Therapeutics Market is valued at around $55 Mn in 2022 and is projected to reach $117 Mn by 2030, exhibiting a CAGR of 9.9% during the forecast period. The market's growth is being driven by the advent of innovative targeted therapies as well as increased awareness, both of which are addressing the growing prevalence of glioma, which is aided by improved diagnostic instruments and early detection procedures. Key players in the Brazil Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Pfizer, AbbVie, Oncoclínica, Cmed, EMS, DASA. Etc.
Philippines Brain Cancer Therapeutics Market
Philippines Brain Cancer Therapeutics Market valued at $5 Mn in 2022, projected to reach $12 Mn by 2030 with a 11.1% CAGR. Anticipated increases in the occurrence of brain cancer, particularly glioblastoma multiforme, are expected to substantially boost the need for treatments targeting brain cancer, thereby impacting the market's overall landscape. Currently, prominent pharmaceutical entities in the market include Merck & Co, Amgen, Roche, Pfizer, Teva Pharmaceutical, Karyopharm Therapeutics, Novartis, AstraZeneca, Bristol Myers Squibb, and Eli Lilly.
UK Constipation Therapeutics Market Analysis
UK Constipation Therapeutics Market was valued at $473 Mn in 2022 and is estimated to reach $673 Mn in 2030, exhibiting a CAGR of 4.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Johnson & Johnson, Norgine Pharmaceuticals, Pfizer, Recordati, Sanofi, and Takeda Pharmaceuticals.
Germany Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Germany Clinical Nutrition for Chronic Kidney Diseases Market was valued at $57.50 Mn in 2023 and is predicted to grow at a CAGR of 4.23% from 2023 to 2030, to $76.80 Mn by 2030. The key drivers of this industry include the high prevalence of CKD, increasing awareness and education, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Philippines Herbal Supplements Market Report
The Philippines Herbal Supplements Market was valued at $11.57 Mn in 2023 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $18.22 Mn by 2030. The key drivers of this industry include a growing middle-class population, rising awareness, and health consciousness. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Dabur, and Amway among others.
Canada Adult Malignant Glioma Therapeutics Market Analysis
The Canada Adult Glioma Therapeutics Market is valued at around $176 Mn in 2022 and is projected to reach $348 Mn by 2030, exhibiting a CAGR of 8.9% during the forecast period. The market is being driven by increased research and development funding, significant government investments in cancer research, owing to the increased prevalence of brain cancers, the presence of unmet healthcare needs, and a favourable regulatory environment that allows for the rapid approval of innovative medicines. Key players in the Canada Adult Malignant Glioma Therapeutics Market include Roche, Merck & Co., Pfizer, Amgen, Arbor Pharmaceuticals, Karyopharm Therapeutics, Azurity Pharmaceuticals. Medicago Inc., CogniMed Therapeutics, Inc., and others
Singapore Herbal Supplements Market Report
The Singapore Herbal Supplements Market was valued at $6.31 Mn in 2023 and is predicted to grow at a CAGR of 6.8% from 2023 to 2030, to $10 Mn by 2030. The key drivers of this industry include an aging population, increasing health awareness, and the prevalence of lifestyle diseases. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Amway, and NOW Foods among others.
UK Brugada Syndrome Market Analysis
The UK Brugada Syndrome Market was valued at $31.2 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $46.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the UK Brugada Syndrome Market are AstraZeneca, Hikma, GlaxoSmithKline, Accord, Siemens Healthineers, Abbott, and Thermo Fisher Scientific, among others.
UAE Brain Cancer Therapeutics Market
UAE Brain Cancer Therapeutics Market valued at $12 Mn in 2022, projected to reach $28 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Roche, Merck, Novartis, Bristol Myers Squibb, Eli Lilly, Pfizer, AstraZeneca, Teva Pharmaceutical Industries, Sanofi, and Ipsen.
Vietnam Constipation Therapeutics Market Analysis
Vietnam Constipation Therapeutics Market was valued at $91 Mn in 2022 and is estimated to reach $153 Mn in 2030, exhibiting a CAGR of 6.73% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise GlaxoSmithKline, Johnson & Johnson, Sanofi, Abbott, Bayer, AstraZeneca, Pfizer, Merck Sharp & Dohme, Boehringer Ingelheim, and United Laboratories.
UK Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UK Clinical Nutrition for Chronic Kidney Diseases Market was valued at $40.80 Mn in 2023 and is predicted to grow at a CAGR of 4.03% from 2023 to 2030, to $53.80 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and the growing geriatric population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Vietnam Herbal Supplements Market Report
The Vietnam Herbal Supplements Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 6.43% from 2023 to 2030, to $40.68 Mn by 2030. The key drivers of this industry include increased awareness, rising disposable income, and expansion of distribution channels. The industry is primarily dominated by players such as Himalaya, Herbalife Nutrition, Patanjali Ayurved, and Sao Thai Duong Company among others.
Egypt Adult Malignant Glioma Therapeutics Market Analysis
The Egypt Adult Glioma Therapeutics Market is valued at around $6 Mn in 2022 and is projected to reach $14 Mn by 2030, exhibiting a CAGR of 10.4% during the forecast period. The Egypt Adult Malignant Glioma Market is driven by factors such as increased advancements in targeted therapies, increased insurance coverage and government support and most importantly, reliance on imported drugs causing low local competitiveness and higher opportunities of growth for newer market players. Key players in the Egypt Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Pharco, Eva Pharma, Siemens, etc. among others
US Brain Cancer Therapeutics Market
US Brain Cancer Therapeutics Market valued at $966 Mn in 2022, projected to reach $1,869 Mn by 2030 with a 8.6% CAGR. A significant rise in the occurrence of brain cancer, specifically glioblastoma multiforme, is expected to drive the demand for treatments in the brain cancer therapeutics market. Top leading pharmaceutical companies currently operating in the industry are Roche, Novartis, Merck, Pfizer, BMS, Bayer, Celgene, AbbVie, Teva Pharmaceuticals, and Spectrum Pharmaceuticals.
China Clinical Nutrition for Chronic Kidney Diseases Market Analysis
China Clinical Nutrition for Chronic Kidney Diseases Market was valued at $126.20 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $209.80 Mn by 2030. The key drivers of this industry include the high prevalence of CKD, increasing awareness and education, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Egypt Herbal Supplements Market Report
The Egypt Herbal Supplements Market was valued at $14.73 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $24.75 Mn by 2030. The key drivers of this industry include rising obesity rates, growing health awareness, and distribution channels. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
China Brugada Syndrome Market Analysis
The China Brugada Syndrome Market was valued at $96.5 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $179.8 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the China Brugada Syndrome Market are AstraZeneca, Abbott, Bayer, Merck, and Sanofi, among others.
